Using CRISPR to study gene function aids understanding of 22q11.2 deletion syndrome

Most high-throughput assays to investigate the role of genes in disease involve in vitro cell models. Now a technology that targets CRISPR–Cas9 gene editing to specific cells in mice, and analyses transcriptional effects in single nuclei, has led to fresh insights into the genes involved in 22q11.2 deletion syndrome.